Category Archives: Cardiovascular Pharmacology

BERLIN and NEW YORK, July 9, 2020 /PRNewswire/ --ATAI Life Sciences AG, a global biotechnology company builder that envisions an end to mental illnesses, has acquired a majority stake in New York-based pharmaceutical company Kures, which targets the important intersection between pain and opioid use disorder. Additionally, Srinivas Rao, MD, PhD, Chief Scientific Officer of ATAI Life Sciences, has been appointed CEO of Kures. Continue reading →

July 06, 2020 01:00 ET | Source: Idorsia Pharmaceuticals Ltd multilang-release Allschwil, Switzerland July 6, 2020 Idorsia Ltd (SIX: IDIA) today announced positive top-line results of the second pivotal Phase 3 study investigating 10 and 25 mg doses of its dual orexin receptor antagonist, daridorexant, in 924 adult and elderly patients (39.3% 65 years) with insomnia. Continue reading →

This post contains affiliate links. When you shop using these links we earn a commission that helps support the website at no extra cost to you allowing us to continue to bring you up to date health and medical news. Vitamin D is often referred to as the sunshine vitamin because of the way it can be made by the body when your skin is exposed to the sun.It is an essential, fat-soluble vitamin, which means that it can be stored in the body for extended periods and it is not excreted out of the body like a water-soluble vitamin Continue reading →

Vancouver, British Columbia--(Newsfile Corp. - June 18, 2020) - The Yield Growth Corp. Continue reading →

Your body knows exactly when to sleep, wake up, eat, exercise, focus on work, rest and sleep again. Continue reading →

Does living near roadways posed a risk to the establishing brain? Continue reading →

By Katie Hunt, CNN (CNN) -- Still taking a daily aspirin to ward off heart attacks? You might want to think again, according to a new review. Aspirin is still one of the most commonly used medications in the world, even though it's no longer recommended as a preventative by many health authorities Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced new research to be highlighted at the Companys third annual Science Day, held virtually this year. The program is designed to provide insight into the continued diverse efforts underway at Moderna and with collaborators to better understand how to use mRNA as a medicine, and underscores the Companys continued commitment to basic science and innovation Continue reading →

Alzheimers disease can be a challenging diagnosis for both the patient and family. It is the most common cause of dementia, accounting for 60-80% of cases and is the 6th leading cause of death in the U.S. Alzheimers is also a leading cause of disability and poor health as disease progression occurs over time Continue reading →

Lab technicians operate a machine to wash empty vials of investigational coronavirus disease (COVID-19) treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, U.S. March 18, 2020. Gilead Sciences Inc | Reuters Repurposing existing drugs will be a quicker way to tackle the coronavirus pandemic than developing a vaccine, scientists have argued Continue reading →